These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2466855)

  • 1. Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study.
    Singerman LJ; Ferris FL; Mowery RP; Brucker AJ; Murphy RP; Lerner BC; Mincey GJ
    J Diabet Complications; 1988; 2(4):189-96. PubMed ID: 2466855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
    Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red krypton and blue-green argon laser diabetic panretinal photocoagulation.
    Blankenship GW; Gerke E; Batlle JF
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(4):364-8. PubMed ID: 2476366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1987; 85():176-94. PubMed ID: 2451871
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
    Little HL
    Ophthalmology; 1985 Feb; 92(2):279-83. PubMed ID: 2580259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers.
    Capoferri C; Bagini M; Chizzoli A; Pece A; Brancato R
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):232-6. PubMed ID: 2361594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of argon green and krypton red laser photocoagulation for patients with diabetic exudative maculopathy.
    Khairallah M; Brahim R; Allagui M; Chachia N
    Br J Ophthalmol; 1996 Apr; 80(4):319-22. PubMed ID: 8703882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red krypton laser therapy of macular and retinal vascular diseases.
    Singerman LJ
    Retina; 1982; 2(1):15-28. PubMed ID: 6184765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argon versus krypton panretinal photocoagulation side effects on the anterior segment.
    Menchini U; Scialdone A; Pietroni C; Carones F; Brancato R
    Ophthalmologica; 1990; 201(2):66-70. PubMed ID: 2234817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krypton red laser photocoagulation of the ocular fundus.
    Yannuzzi LA; Shakin JL
    Retina; 1982; 2(1):1-14. PubMed ID: 6184764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers.
    Casswell AG; Canning CR; Gregor ZJ
    Eye (Lond); 1990; 4 ( Pt 5)():668-72. PubMed ID: 2282940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].
    Ulbig MW; Hamilton AM
    Ophthalmologe; 1993 Oct; 90(5):457-62. PubMed ID: 8219631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time.
    Bandello F; Brancato R; Trabucchi G; Lattanzio R; Malegori A
    Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):491-4. PubMed ID: 8224951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization.
    Tasman W; Magargal LE; Augsburger JJ
    Ophthalmology; 1980 May; 87(5):400-2. PubMed ID: 6157141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ophthalmoscopic and fluorographic aspects of diabetic retinopathy before and after argon laser photocoagulation].
    Verougstraete C; Toussaint D
    Bull Soc Belge Ophtalmol; 1980; (188-189):137-56. PubMed ID: 6166341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for and technics of argon laser photocoagulation in diabetic retinopathy].
    Coscas G
    Bull Soc Belge Ophtalmol; 1980; (188-189):119-35. PubMed ID: 6166340
    [No Abstract]   [Full Text] [Related]  

  • 19. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1987 Nov; 105(11):1499-507. PubMed ID: 2445326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):832-7. PubMed ID: 1693498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.